The relationship between depression and diabetes complications appears to be bidirectional, although depression was associated with an increased risk for incident macrovascular and microvascular disease.
Youth at risk for depression could benefit from prevention efforts that target the student’s ability to manage environmental stressors like school transitions.
Investigators found no evidence that depression is associated with happy and sad emotion recognition; however, those with severe depression did not misclassify ambiguous faces as happy.
Older adults with severe depressive symptoms are more likely to be taking high-potency opioid medications compared with older adults without such symptoms.
Physicians may need to be sensitive to depression and anxiety in their patients with hidradenitis suppurativa.
Patients with lymphoma or myeloma were assessed prior to and 1 month after initiating chemotherapy for depressive symptoms.
Pear Therapeutics is seeking marketing authorization from the Food and Drug Administration (FDA) for Somryst, a prescription digital therapeutic (PDT) intended for use in the treatment of adults with chronic insomnia and depression.
In patients with Parkinson disease who receive subthalamic nucleus deep brain stimulation, suicide behaviors tend to occur during the first 3 years after the procedure.
The benefit of CPAP was seen for depression but not anxiety symptoms in patients with obstructive sleep apnea.
Screening for and treating depression in patients with diabetes may be associated with a lower mortality risk.
